Genetic analysis in families with amyotrophic lateral sclerosis
肌萎缩侧索硬化症家族的遗传分析
基本信息
- 批准号:11470144
- 负责人:
- 金额:$ 8.64万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Amyotrophic lateral screlosis (ALS) is a fatal neurodegenerative disease caused by selective death of motor neurons. Pathological studies of postmortem ALS patients revealed motor neuron loss in the anterior horn of the spinal cord, the nucleus of brainstem and the cortex. Approximately 10% of cases of ALS are inherited, usually as an autosomal dominant trait. Mutations of the cytosolic cupper-zinc superoxide dismutase (Cu/Zn SOD) gene were detected in about 25% of patients with familial ALS and until now more than 70 different mutations are known. In this study, we carry out a linkage analysis using a large Japanese family with ALS to identify loci that contain genes whose defects cause ALS.We did not detect any genetic linkage to the known locus of motor neuron diseases and now going on a genome-wide linkage analysis. In addition, we identified a novel missense mutation of the Cu/Zn SOD gene (Leu126Ser) in a Japanese family with ALS that included a patient with the homozygous mutation. The expression of the Cu/Zn SOD polypeptide in erythrocytes was markedly reduced in the case with the homozygous mutation compared to those with the heterozygous mutation. We speculated that this reduction of the mutant Cu/Zn SOD molecule may be related to the severe clinical phenotype of the case.
肌萎缩侧索硬化症(Amyotrophic lateral screlosis,ALS)是一种由运动神经元选择性死亡引起的致死性神经退行性疾病。ALS患者死后病理学检查显示脊髓前角、脑干核团和皮质运动神经元丢失。大约10%的ALS病例是遗传的,通常是常染色体显性遗传。在大约25%的家族性ALS患者中检测到细胞溶质铜锌超氧化物歧化酶(Cu/Zn SOD)基因突变,迄今为止已知有70多种不同的突变。在这项研究中,我们进行了连锁分析,使用一个大的日本家庭与ALS,以确定位点,包含基因的缺陷导致ALS。我们没有检测到任何遗传连锁的已知位点的运动神经元疾病,现在正在进行全基因组的连锁分析。此外,我们确定了一个新的错义突变的铜/锌SOD基因(Leu 126 Ser)在日本的ALS家族,其中包括一个纯合突变的患者。与杂合突变相比,纯合突变的红细胞中Cu/Zn SOD多肽的表达显著降低。我们推测突变型Cu/Zn SOD分子的这种减少可能与该病例的严重临床表型有关。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Trotti D et al.: "Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity."J Biol Chem. 276. 576-582 (2001)
Trotti D 等人:“肌萎缩侧索硬化症相关的谷氨酸转运蛋白突变体具有受损的谷氨酸清除能力。”J Biol Chem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tsuchiya K et al.: "Familial amyotrophic lateral sclerosis with posterior column degeneration and basophilic inclusion bodies : a clinical, genetic and pathological study."Clin Neuropath. (印刷中).
Tsuchiya K 等人:“伴有后柱变性和嗜碱性包涵体的家族性肌萎缩侧索硬化症:临床、遗传和病理学研究。”Clin Neuropath(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Onodera Y, Aoki M, Tsuda T, Kato H, Nagata T, Kameya T, Abe K and Itoyama Y.: "High preverance of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan"J Neurol Sci. 178. 155-160 (2000)
Onodera Y、Aoki M、Tsuda T、Kato H、Nagata T、Kameya T、Abe K 和 Itoyama Y.:“日本偏远地区 1 型脊髓小脑共济失调 (SCA1) 的患病率很高”J Neurol Sci。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Trotti D, Aoki M, Pasinelli P, Berger UV, Danbolt NC, Brown RH Jr and Hediger MA: "Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity."J Biol Chem. 276. 576-582 (2001)
Trotti D、Aoki M、Pasinelli P、Berger UV、Danbolt NC、Brown RH Jr 和 Hediger MA:“肌萎缩侧索硬化症相关谷氨酸转运蛋白突变体具有受损的谷氨酸清除能力。”J Biol Chem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Onodera Y et al.: "High prevalence of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan"J Neurol Sci. 178. 155-160 (2000)
Onodera Y 等人:“日本偏远地区 1 型脊髓小脑共济失调 (SCA1) 的患病率很高”J Neurol Sci。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ITOYAMA Yasuto其他文献
ITOYAMA Yasuto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ITOYAMA Yasuto', 18)}}的其他基金
Establishment of a new disease entity as astrocytopathy, and studies on the pathogenesis and treatment for neuromyelitis optica
星形细胞病新病种的建立及视神经脊髓炎的发病机制和治疗研究
- 批准号:
22229008 - 财政年份:2010
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Elucidate the pathomechanism of inclusion body myositis(IBM)
阐明包涵体肌炎(IBM)的发病机制
- 批准号:
22659167 - 财政年份:2010
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Optic-spinal multiple sclerosis : clarification of pathogenesis, establishment of new disease entity and treatment
视脊髓多发性硬化症:发病机制的阐明、新疾病实体的建立和治疗
- 批准号:
19209032 - 财政年份:2007
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A Study on the Pathogenesis and Therapy of Optic-Spinal Multiple Sclerosis
视神经脊髓多发性硬化症的发病机制及治疗研究
- 批准号:
17390250 - 财政年份:2005
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
COMPARATIVE ANALYSIS OF CLINICAL AND MOLECULAR IMMUNOLOGICAL PATHOGENESES IN SUBTYPES OF MULTIPLE SCLEROSIS IN JAPAN
日本多发性硬化症亚型临床及分子免疫病因比较分析
- 批准号:
15390271 - 财政年份:2003
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Comparative analysis of molecular immunopathogenesis in optic-spinal and conventional multiple sclerosis
视神经脊髓病与传统多发性硬化症分子免疫发病机制的比较分析
- 批准号:
13470131 - 财政年份:2001
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mutational analysis in dysferlin gene in patients with muscular dystrophy in Japanese populations.
日本人群肌营养不良症患者 Dysferlin 基因突变分析。
- 批准号:
12557058 - 财政年份:2000
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical epidemiology and analysis of pathomechanisms of optic-spinal form of multiple sclerosis
视脊髓型多发性硬化症的临床流行病学及发病机制分析
- 批准号:
09470150 - 财政年份:1997
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular genetic study of familial ALS in Japan
日本家族性 ALS 的分子遗传学研究
- 批准号:
07457152 - 财政年份:1995
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study of Immunomechanisms in HTLV-I-Associated Myelopathy(HAM)
HTLV-I相关性脊髓病(HAM)的免疫机制研究
- 批准号:
63480217 - 财政年份:1988
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 8.64万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 8.64万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 8.64万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
Operating Grants